WRF Capital — Full Portfolio

Accipiter Biosciences uses computational protein design to develop de novo, single-agent protein therapies that engage multiple cell-surface receptors at once, functioning as agonists.

AI & Machine LearningBiotechDeep TechSeattle, US

Matthew Bick(Executive Officer, Director, Promoter)inJavier Castellanos(Executive Officer, Director, Promoter)Hector De Jesus Rincon Arano(Executive Officer, Promoter)Heather Redman(Director)Randall Schatzman(Director)William Canestaro(Executive Officer)

Co-investorsArgonautic VenturesColumbus Venture PartnersPack Ventures

Seattle, US

JACOB O. WOBBROCK(Executive Officer)WILLIAM T. COLLERAN(Executive Officer, Director)ANDREW KO(Executive Officer)

BoardWILLIAM MCALEER(Director)inMARK UPSON(Director)MICHAEL FRIDGEN(Director)

Co-investorsCowles VenturesThe W FundVoyager Capital

Automates complex call center operations; acquired by Sagility Health.

Co-investorsAllen Institute for AI (AI2) IncubatorFlare Capital PartnersAI GrantRadical Ventures

Fred Hutch is a cancer research institute that develops biomarkers, therapies, and stem cell products for research and clinical use, and provides data infrastructure and funding to commercialize discoveries into treatments and spinout companies.

BiotechHealthtechMedical DevicesSeattle, US

The Institute for Systems Biology (ISB) is a research organization focused on systems biology science and education, including curriculum development, educator engagement, and student research programs.

Biotech

Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for substance use disorders and specialty central nervous system (CNS) conditions, including treatments for opioid withdrawal and seizure disorders.

BiotechHealthtechSeattle, US

CHRISTOPHER TOOMBS(Executive Officer)LINDSAY RAYLE(Executive Officer, Promoter)M. Johnston Erwin(Director)David Schubert(Executive Officer, Promoter)

BoardSTEVEN GILLIS(Director)inThong Le(Executive Officer, Director, Promoter)

Co-investorsACCELERATOR LIFE SCIENCE PARTNERSARCH Venture Partners

Biopharma company developing non-immunosuppressive drugs for autoimmune diseases.

Co-investorsNew Science VenturesEaston Capital

University of Washington is a public research institution offering undergraduate, graduate, and professional education across multiple campuses and disciplines including engineering, computer science, business, medicine, law, and environmental studies.

EdTechSeattle, US

Co-investorsShumo Chu

Washington State University is a public research institution operating six campuses across Washington state and online, offering academic programs in fields including health sciences, STEM, business, engineering, and social sciences.

EdTechPullman, US